CANF

Can-Fite BioPharma Ltd. - ADR

3.23

USD

CANF Earnings Reports

Positive Surprise Ratio

CANF beat 4 of 4 last estimates.

100%

Next Report

Date of Next Report

Apr 12, 2026

Estimate for Q4 25 (Revenue/ EPS)

Implied change from Q-- -- (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

Can-Fite BioPharma Ltd. - ADR earnings per share and revenue

On --, CANF reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Talphera, Inc. Common Stock

Report Date

Mar 23, 2026 For Q4 25

Estimate

-$0.08

Actual

-$0.06

Surprise

+26.47%

Theravance Biopharma, Inc.

Report Date

Mar 19, 2026 For Q4 25

Estimate

$1.24

Actual

$0.21

Surprise

-83.12%

Relmada Therapeutics, Inc. Common Stock

Report Date

Mar 19, 2026 For Q4 25

Estimate

-$0.14

Actual

-$0.28

Surprise

-103.08%

Context Therapeutics Inc. Common Stock

Report Date

Mar 23, 2026 For Q4 25

Estimate

-$0.10

Actual

-$0.14

Surprise

-29.39%

Avalo Therapeutics, Inc. Common Stock

Report Date

Mar 23, 2026 For Q4 25

Estimate

-$1.49

Actual

-$1.12

Surprise

+24.33%

Journey Medical Corporation Common Stock

Report Date

Mar 25, 2026 For Q4 25

Estimate

-$0.05

Actual

-$0.04

Surprise

+31.86%

Surrozen, Inc. Common

Report Date

Mar 30, 2026 For Q4 25

Estimate

-$1.21

Actual

Surprise

Achieve Life Sciences, Inc.

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.27

Actual

-$0.28

Surprise

-1.12%

Pyxis Oncology, Inc. Common Stock

Report Date

Mar 23, 2026 For Q4 25

Estimate

-$0.34

Actual

-$0.28

Surprise

+15.55%

Fractyl Health, Inc. Common Stock

Report Date

Mar 24, 2026 For Q4 25

Estimate

-$0.18

Actual

$0.15

Surprise

+181.70%

FAQ

What were Can-Fite BioPharma Ltd. - ADR's earnings and revenue for the latest quarter Q-- --?

For Q-- --, Can-Fite BioPharma Ltd. - ADR reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.

How did the market react to Can-Fite BioPharma Ltd. - ADR's Q-- -- earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Can-Fite BioPharma Ltd. - ADR expected to report next?

The next earning report is scheduled for Apr 12, 2026.

What are the forecasts for Can-Fite BioPharma Ltd. - ADR's next earnings report?

Based on -- analysts, Can-Fite BioPharma Ltd. - ADR is expected to report EPS of -- and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.